524 Scaife Hall

412-648-8957

http://www.gradbiomed.pitt.edu

gradstudies@medschool.pitt.edu

The Cellular and Molecular Pathology (CMP) Program is a PhD-granting program that integrates Cellular and Molecular Biology with the study of human diseases, generally in the context of Regenerative Medicine with directore translational goals. Admission into the program occurs through the Interdisciplinary Biomedical Graduate Program or the Medical Scientist Training Program. Utilizing the latest technologies, CMP emphasizes tissue biology in both health and disease using normal and/or diseased tissues and cells to solve both basic and applied research problems. The faculty research interests include pathobiologies of the liver, lung, kidney, brain, bone, prostate, and breast with an accent on the areas of cancer biology, tissue and organ regeneration, stem cells, embryonic development, angiogenesis, neurodegeneration, and wound healing. Faculty in our program come from the Divisions of Experimental Pathology and of Neuropathology within the Department of Pathology, as well as many other basic and clinical departments in the School of Medicine. Our faculty (a mix of MDs, PhDs, and MD/PhDs) and their students work on the main campus as well as within the University of Pittsburgh Cancer Institute, the Rangos Research Institute at the Children's Hospital of Pittsburgh, the McGowan Institute of Regenerative Medicine, and the Thomas E. Starzl Transplantation Institute. Graduate students at these facilities are able to use state of the art technologies (i.e. imaging, microarrays, proteomics) and a variety of in vitro/in vivo models to study normal and disease processes, in basic and applied contexts.